Identifying Obesity and Obesity Complications in Pediatrics PI: Sandra Benavides, PharmD Co-I: Jessica M. DeLeon, PhD Co-I: Magdaline Exantus, BS Background & Significance From: http://www.cdc.gov/nchs/data/hestat/obesity_child_07_08/obesity_child_07_08.htm, accessed 1/9/11 From: http://www.cdc.gov/nchs/data/hestat/obesity_child_07_08/obesity_child_07_08.htm, accessed 1/9/11 Florida Overweight & Obesity Rates From: The Report of the Governor’s Task Force on the Obesity Epidemic. Florida Overweight & Obesity Rates From: The Report of the Governor’s Task Force on the Obesity Epidemic. Complications of Obesity From: http://mozartinshape.org/misvsobesity/whymis.php?id=ch02, accessed 1/9/11 Current Problem • High rates in south Florida • US Preventive Services Task Force recommends all children > 6 years be screened1 • In clinical practice, barriers exist in timely identification of obesity and complications • On study reports only 34% of obese patients were correctly identified2 • Only 8% of general pediatric visits have screening for complications3 Current Problem • Reasons for under-diagnosis may be4,5 ▫ ▫ ▫ ▫ Time limitations Limited knowledge of diagnostic criteria Poor patient counseling techniques Lack of effective interventions Objective of Study Develop a Center for Child and Adolescent Health (CCAH) • Pharmacist-managed clinic • Screen and identify children & adolescents with obesity or complications of obesity • Pharmacist will provide assessments of children & adolescents requiring further treatment/referral • CCAH will provide patient education on wellness and pharmacotherapy (when indicate) Research Design & Methods Specific Aims: • Specific Aim 1: ▫ Development of the CCAH • Specific Aim 2: ▫ Identify and assess children & adolescents at high risk for developing complications secondary to obesity • Specific Aim 3: ▫ Assess the patient and parent/guardian satisfaction with the clinic and perform a needs assessment to determine future weight loss intervention strategies SA 1: Development of the CCAH • • • • • • Pharmacist managed Two days per week (10-15 hours) Located in proximity to Pediatricians Referred by Pediatrician or self-referral Detailed to all Pediatricians in area Serve as a clerkship site to 4th year pharmacy students SA 2: Assessment of Children • Assessments conducted ▫ ▫ ▫ ▫ ▫ Complete medical history Weight, height, body mass index Waist circumference Blood pressure measurement Point-of-care testing Blood glucose Lipid profile (TC, HDL, LDL, triglycerides) High sensitivity C-reactive protein ▫ Quality of life assessment SA 2: Assessment of Children • Detailed analysis provided to referring physician with recommendations ▫ Further testing ▫ Treatment • When indicated, referral to dietician and/or fitness program • Pharmacist will educate the child/adolescent and parent/guardian one healthy lifestyle ▫ Exercise ▫ Disease prevention ▫ Medication (when appropriate) SA 3: Patient satisfaction/needs assessment • Survey provided to child/adolescent ▫ Satisfaction with the CCAH ▫ Determine what activities the child/adolescent would be interested in participating in • Survey provided to parent/guardian ▫ Satisfaction with the CCAH Study Participants • Available for all children & adolescents ages 6-18 • Will exclude pregnant females • No cost to the child/adolescent • Will not bill insurance Data Analysis & Measurement Instruments SA 1: Development of CCAH • Primary outcome: ▫ Utilization (referrals) of the CCAH Number (%) of physicians referring patients Number (%) of children & adolescents attending • Secondary outcome: ▫ Viability of the CCAH as a 4th year pharmacy clerkship site Ability to meet learning outcomes required SA 2: Assessment of Children • Primary outcome: ▫ Improvements in the following parameters Weight and BMI Waist circumference Diastolic and systolic blood pressure Blood glucose Total cholesterol, HDL, LDL, triglycerides hs-CRP Quality of life assessment ▫ Descriptive, 2-tailed paired t-test (QOL—Mann Whitney t-test), p<0.05 SA 3: Patient satisfaction/needs assessment • Primary outcome ▫ Satisfaction and acceptance of CCAH by children/adolescents and parents Data collected from surveys Current status… Obstacles • Community partner is no longer involved • Explored other community partners ▫ FLIPANY • Potential future partners being considered ▫ Memorial Regional Hospital ▫ Pediatric Associates References 1. 2. 3. 4. 5. US Preventive Services Task Force. Screening for obesity in children and adolescents: US Preventive Services Task Force Recommendation Statement. Pediatrics 2010;361-7. Benson L, et al. Trends in the diagnosis of overweight and obesity in children and adolescents: 1999-2007. Pediatrics 2009;123:e153-8. Riley MR, et al. Underdiagnosis of pediatric obesity and underscreening for fatty liver disease and metabolic syndrome by pediatricians and pediatric subspecialties. J Pediatr 2005;147:839-42. Dorsey KB, et al. Diagnosis, evaluation, and treatment of childhood obesity in pediatric practice. Arch Pediatr Adolesc Med 2005;159:632-8. Spivack JG, et al. Primary care providers’ knowledge, practices and perceived barriers to the treatment and prevention of childhood obesity. Obesity 2009;1-7 (advanced online publication) DOI: 10.1038/oby.2009.410 Stature-for-age & Weight-for-age Percentiles Available at: http://www.cdc.gov/growthcharts/ BMI-for-age Percentile Available at: http://www.cdc.gov/growthcharts/ Blood Pressure in Pediatrics Lipid and Lipoprotein Distribution in Ages 5-19 years From: Pediatrics 2008;122:198-208